I'd much prefer to see a roadshow to HNW/UHNW individuals in the US and EU/Switzerland where a solid development plan was laid out in combination with a $50mil-$100mil raise.
I don't mind more dilution provided the funds received are from the right sort of investor and I'd much prefer to see a dilution in power of some of the existing 'so called' cornerstone investors.
IMHO you can only get the (say 2x?) bump in share price for a takeover/merger once, it's be great to see that happen off a much higher base and not give away control/equity in the hopes the a NASDAQ listing will see a positive re-rate.
Wolgen who heads up $CUV has a 21 point checklist that he is looking to tick off before listing on NASDAQ, he has reviewed the performance of the healthcare/biotech players in the index and listing is not a sure thing for positive re-rate.
(All IMHO, pls DYOR)
I'd much prefer to see a roadshow to HNW/UHNW individuals...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.15 |
Change
-0.250(2.40%) |
Mkt cap ! $214.5M | |||
| Open | High | Low | Value | Volume |
| $10.57 | $10.59 | $9.90 | $181.3K | 17.70K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 720 | $10.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.35 | 3407 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |